Client core business
Rejuvenate Biomed is involved in research and treatment development in the domain of healthy aging. Their business goal is to develop medicines that act on age-related processes in the human body, increasing cell resilience and postponing – or eliminating – age-related disease.
How Modis added value
The client sought non-dilutive funding to complement other financing options. We developed a tailored grant strategy for them, successfully achieving approval for a 0.5 million-euro research grant through the Flemish grant scheme VLAIO within the first year. Moving forward, we aim to help the client apply for additional VLAIO and EU grants.